The SiroSkin study: A multi-centre randomised double-blind placebo-controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ... (Stream 7) (2022-2027)
Experts
Professor
Kiarash Khosrotehrani
Director, Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences